AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
AdvanCell Isotopes ²¹²Pb Generator
2023

Share:

AdvanCell Isotopes ²¹²Pb Generator

Radiopharmaceutical Alpha Isotope Generator

The AdvanCell ²¹²Pb Generator is a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy – the reliable & scalable supply of isotope. The manufacture of clinical doses of a high-value isotope Alpha 212® (Lead-212) for use in targeted radionuclides therapy is a gamechanger for prostate & several other cancer treatments. Due to Lead-212’s short half-life, transporting, storing & administering the isotope is time sensitive. Scalable local production of these rare alpha emitting isotopes & turning them into cancer therapies enables greater access to treatments for patients who need it most.

Client / Manufacturer

AdvanCell Isotopes

Sydney, AU
Design
DESIGN + INDUSTRY

DESIGN + INDUSTRY

Balmain, AU
Date of Launch
2022
Development Time
more than 36 Month
Target Regions
North America, Asia, Australia / Oceania, Europe
Target Groups
Consumers / Users, Trade / Industry, Public Sector / Government

RELATED PROJECTS